Global Nuclear Receptor ROR Gamma Sales Market Report 2021

Global Nuclear Receptor ROR Gamma Sales Market Report 2021

Table of Contents
1 Nuclear Receptor ROR Gamma Market Overview
1.1 Nuclear Receptor ROR Gamma Product Scope
1.2 Nuclear Receptor ROR Gamma Segment by Type
1.2.1 Global Nuclear Receptor ROR Gamma Sales by Type (2016 & 2021 & 2027)
1.2.2 BBI-6000
1.2.3 GRC-39815Action
1.2.4 R&D Progress
1.2.5 GSK-2981278
1.2.6 IMU-366
1.2.7 INV-17
1.2.8 Others
1.3 Nuclear Receptor ROR Gamma Segment by Application
1.3.1 Global Nuclear Receptor ROR Gamma Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Chronic Obstructive Pulmonary Disease
1.3.3 Asthma
1.3.4 Axial Spondyloarthritis
1.3.5 Breast Cancer
1.3.6 Others
1.4 Nuclear Receptor ROR Gamma Market Estimates and Forecasts (2016-2027)
1.4.1 Global Nuclear Receptor ROR Gamma Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Nuclear Receptor ROR Gamma Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Nuclear Receptor ROR Gamma Price Trends (2016-2027)
2 Nuclear Receptor ROR Gamma Estimates and Forecasts by Region
2.1 Global Nuclear Receptor ROR Gamma Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Nuclear Receptor ROR Gamma Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Nuclear Receptor ROR Gamma Sales Market Share by Region (2016-2021)
2.2.2 Global Nuclear Receptor ROR Gamma Revenue Market Share by Region (2016-2021)
2.3 Global Nuclear Receptor ROR Gamma Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Nuclear Receptor ROR Gamma Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Nuclear Receptor ROR Gamma Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Nuclear Receptor ROR Gamma Estimates and Projections (2016-2027)
2.4.2 Europe Nuclear Receptor ROR Gamma Estimates and Projections (2016-2027)
2.4.3 China Nuclear Receptor ROR Gamma Estimates and Projections (2016-2027)
2.4.4 Japan Nuclear Receptor ROR Gamma Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Nuclear Receptor ROR Gamma Estimates and Projections (2016-2027)
2.4.6 India Nuclear Receptor ROR Gamma Estimates and Projections (2016-2027)
3 Global Nuclear Receptor ROR Gamma Competition Landscape by Players
3.1 Global Top Nuclear Receptor ROR Gamma Players by Sales (2016-2021)
3.2 Global Top Nuclear Receptor ROR Gamma Players by Revenue (2016-2021)
3.3 Global Nuclear Receptor ROR Gamma Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nuclear Receptor ROR Gamma as of 2020)
3.4 Global Nuclear Receptor ROR Gamma Average Price by Company (2016-2021)
3.5 Manufacturers Nuclear Receptor ROR Gamma Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Nuclear Receptor ROR Gamma Market Size by Type
4.1 Global Nuclear Receptor ROR Gamma Historic Market Review by Type (2016-2021)
4.1.1 Global Nuclear Receptor ROR Gamma Sales Market Share by Type (2016-2021)
4.1.2 Global Nuclear Receptor ROR Gamma Revenue Market Share by Type (2016-2021)
4.1.3 Global Nuclear Receptor ROR Gamma Price by Type (2016-2021)
4.2 Global Nuclear Receptor ROR Gamma Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Nuclear Receptor ROR Gamma Sales Forecast by Type (2022-2027)
4.2.2 Global Nuclear Receptor ROR Gamma Revenue Forecast by Type (2022-2027)
4.2.3 Global Nuclear Receptor ROR Gamma Price Forecast by Type (2022-2027)
5 Global Nuclear Receptor ROR Gamma Market Size by Application
5.1 Global Nuclear Receptor ROR Gamma Historic Market Review by Application (2016-2021)
5.1.1 Global Nuclear Receptor ROR Gamma Sales Market Share by Application (2016-2021)
5.1.2 Global Nuclear Receptor ROR Gamma Revenue Market Share by Application (2016-2021)
5.1.3 Global Nuclear Receptor ROR Gamma Price by Application (2016-2021)
5.2 Global Nuclear Receptor ROR Gamma Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Nuclear Receptor ROR Gamma Sales Forecast by Application (2022-2027)
5.2.2 Global Nuclear Receptor ROR Gamma Revenue Forecast by Application (2022-2027)
5.2.3 Global Nuclear Receptor ROR Gamma Price Forecast by Application (2022-2027)
6 North America Nuclear Receptor ROR Gamma Market Facts & Figures
6.1 North America Nuclear Receptor ROR Gamma Sales by Company
6.1.1 North America Nuclear Receptor ROR Gamma Sales by Company (2016-2021)
6.1.2 North America Nuclear Receptor ROR Gamma Revenue by Company (2016-2021)
6.2 North America Nuclear Receptor ROR Gamma Sales Breakdown by Type
6.2.1 North America Nuclear Receptor ROR Gamma Sales Breakdown by Type (2016-2021)
6.2.2 North America Nuclear Receptor ROR Gamma Sales Breakdown by Type (2022-2027)
6.3 North America Nuclear Receptor ROR Gamma Sales Breakdown by Application
6.3.1 North America Nuclear Receptor ROR Gamma Sales Breakdown by Application (2016-2021)
6.3.2 North America Nuclear Receptor ROR Gamma Sales Breakdown by Application (2022-2027)
7 Europe Nuclear Receptor ROR Gamma Market Facts & Figures
7.1 Europe Nuclear Receptor ROR Gamma Sales by Company
7.1.1 Europe Nuclear Receptor ROR Gamma Sales by Company (2016-2021)
7.1.2 Europe Nuclear Receptor ROR Gamma Revenue by Company (2016-2021)
7.2 Europe Nuclear Receptor ROR Gamma Sales Breakdown by Type
7.2.1 Europe Nuclear Receptor ROR Gamma Sales Breakdown by Type (2016-2021)
7.2.2 Europe Nuclear Receptor ROR Gamma Sales Breakdown by Type (2022-2027)
7.3 Europe Nuclear Receptor ROR Gamma Sales Breakdown by Application
7.3.1 Europe 138 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 138 Sales Breakdown by Application (2022-2027)
8 China Nuclear Receptor ROR Gamma Market Facts & Figures
8.1 China Nuclear Receptor ROR Gamma Sales by Company
8.1.1 China Nuclear Receptor ROR Gamma Sales by Company (2016-2021)
8.1.2 China Nuclear Receptor ROR Gamma Revenue by Company (2016-2021)
8.2 China Nuclear Receptor ROR Gamma Sales Breakdown by Type
8.2.1 China Nuclear Receptor ROR Gamma Sales Breakdown by Type (2016-2021)
8.2.2 China Nuclear Receptor ROR Gamma Sales Breakdown by Type (2022-2027)
8.3 China Nuclear Receptor ROR Gamma Sales Breakdown by Application
8.3.1 China 164 Sales Breakdown by Application (2016-2021)
8.3.2 China 164 Sales Breakdown by Application (2022-2027)
9 Japan Nuclear Receptor ROR Gamma Market Facts & Figures
9.1 Japan Nuclear Receptor ROR Gamma Sales by Company
9.1.1 Japan Nuclear Receptor ROR Gamma Sales by Company (2016-2021)
9.1.2 Japan Nuclear Receptor ROR Gamma Revenue by Company (2016-2021)
9.2 Japan Nuclear Receptor ROR Gamma Sales Breakdown by Type
9.2.1 Japan Nuclear Receptor ROR Gamma Sales Breakdown by Type (2016-2021)
9.2.2 Japan Nuclear Receptor ROR Gamma Sales Breakdown by Type (2022-2027)
9.3 Japan Nuclear Receptor ROR Gamma Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Nuclear Receptor ROR Gamma Market Facts & Figures
10.1 Southeast Asia Nuclear Receptor ROR Gamma Sales by Company
10.1.1 Southeast Asia Nuclear Receptor ROR Gamma Sales by Company (2016-2021)
10.1.2 Southeast Asia Nuclear Receptor ROR Gamma Revenue by Company (2016-2021)
10.2 Southeast Asia Nuclear Receptor ROR Gamma Sales Breakdown by Type
10.2.1 Southeast Asia Nuclear Receptor ROR Gamma Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Nuclear Receptor ROR Gamma Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Nuclear Receptor ROR Gamma Sales Breakdown by Application
10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)
11 India Nuclear Receptor ROR Gamma Market Facts & Figures
11.1 India Nuclear Receptor ROR Gamma Sales by Company
11.1.1 India Nuclear Receptor ROR Gamma Sales by Company (2016-2021)
11.1.2 India Nuclear Receptor ROR Gamma Revenue by Company (2016-2021)
11.2 India Nuclear Receptor ROR Gamma Sales Breakdown by Type
11.2.1 India Nuclear Receptor ROR Gamma Sales Breakdown by Type (2016-2021)
11.2.2 India Nuclear Receptor ROR Gamma Sales Breakdown by Type (2022-2027)
11.3 India Nuclear Receptor ROR Gamma Sales Breakdown by Application
11.3.1 India Nuclear Receptor ROR Gamma Sales Breakdown by Application (2016-2021)
11.3.2 India Nuclear Receptor ROR Gamma Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Nuclear Receptor ROR Gamma Business
12.1 Genfit SA
12.1.1 Genfit SA Corporation Information
12.1.2 Genfit SA Business Overview
12.1.3 Genfit SA Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Genfit SA Nuclear Receptor ROR Gamma Products Offered
12.1.5 Genfit SA Recent Development
12.2 GlaxoSmithKline Plc
12.2.1 GlaxoSmithKline Plc Corporation Information
12.2.2 GlaxoSmithKline Plc Business Overview
12.2.3 GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2016-2021)
12.2.4 GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Products Offered
12.2.5 GlaxoSmithKline Plc Recent Development
12.3 Aurigene Discovery Technologies
12.3.1 Aurigene Discovery Technologies Corporation Information
12.3.2 Aurigene Discovery Technologies Business Overview
12.3.3 Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Products Offered
12.3.5 Aurigene Discovery Technologies Recent Development
12.4 Beijing Hanmi Pharmaceutical
12.4.1 Beijing Hanmi Pharmaceutical Corporation Information
12.4.2 Beijing Hanmi Pharmaceutical Business Overview
12.4.3 Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Products Offered
12.4.5 Beijing Hanmi Pharmaceutical Recent Development
12.5 Biogen Inc
12.5.1 Biogen Inc Corporation Information
12.5.2 Biogen Inc Business Overview
12.5.3 Biogen Inc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Biogen Inc Nuclear Receptor ROR Gamma Products Offered
12.5.5 Biogen Inc Recent Development
12.6 AbbVie Inc
12.6.1 AbbVie Inc Corporation Information
12.6.2 AbbVie Inc Business Overview
12.6.3 AbbVie Inc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2016-2021)
12.6.4 AbbVie Inc Nuclear Receptor ROR Gamma Products Offered
12.6.5 AbbVie Inc Recent Development
12.7 Eurofins Advinus
12.7.1 Eurofins Advinus Corporation Information
12.7.2 Eurofins Advinus Business Overview
12.7.3 Eurofins Advinus Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Eurofins Advinus Nuclear Receptor ROR Gamma Products Offered
12.7.5 Eurofins Advinus Recent Development
12.8 Brickell Biotech Inc
12.8.1 Brickell Biotech Inc Corporation Information
12.8.2 Brickell Biotech Inc Business Overview
12.8.3 Brickell Biotech Inc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Brickell Biotech Inc Nuclear Receptor ROR Gamma Products Offered
12.8.5 Brickell Biotech Inc Recent Development
12.9 Pfizer Inc
12.9.1 Pfizer Inc Corporation Information
12.9.2 Pfizer Inc Business Overview
12.9.3 Pfizer Inc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Pfizer Inc Nuclear Receptor ROR Gamma Products Offered
12.9.5 Pfizer Inc Recent Development
12.10 Phenex Pharmaceuticals AG
12.10.1 Phenex Pharmaceuticals AG Corporation Information
12.10.2 Phenex Pharmaceuticals AG Business Overview
12.10.3 Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Products Offered
12.10.5 Phenex Pharmaceuticals AG Recent Development
12.11 Reata Pharmaceuticals Inc
12.11.1 Reata Pharmaceuticals Inc Corporation Information
12.11.2 Reata Pharmaceuticals Inc Business Overview
12.11.3 Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Products Offered
12.11.5 Reata Pharmaceuticals Inc Recent Development
12.12 Bristol-Myers Squibb Company
12.12.1 Bristol-Myers Squibb Company Corporation Information
12.12.2 Bristol-Myers Squibb Company Business Overview
12.12.3 Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Products Offered
12.12.5 Bristol-Myers Squibb Company Recent Development
12.13 Celgene Corp
12.13.1 Celgene Corp Corporation Information
12.13.2 Celgene Corp Business Overview
12.13.3 Celgene Corp Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Celgene Corp Nuclear Receptor ROR Gamma Products Offered
12.13.5 Celgene Corp Recent Development
12.14 Eli Lilly
12.14.1 Eli Lilly Corporation Information
12.14.2 Eli Lilly Business Overview
12.14.3 Eli Lilly Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Eli Lilly Nuclear Receptor ROR Gamma Products Offered
12.14.5 Eli Lilly Recent Development
12.15 Glenmark Pharmaceuticals
12.15.1 Glenmark Pharmaceuticals Corporation Information
12.15.2 Glenmark Pharmaceuticals Business Overview
12.15.3 Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Products Offered
12.15.5 Glenmark Pharmaceuticals Recent Development
12.16 Lead Pharma Holding BV
12.16.1 Lead Pharma Holding BV Corporation Information
12.16.2 Lead Pharma Holding BV Business Overview
12.16.3 Lead Pharma Holding BV Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Lead Pharma Holding BV Nuclear Receptor ROR Gamma Products Offered
12.16.5 Lead Pharma Holding BV Recent Development
13 Nuclear Receptor ROR Gamma Manufacturing Cost Analysis
13.1 Nuclear Receptor ROR Gamma Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Nuclear Receptor ROR Gamma
13.4 Nuclear Receptor ROR Gamma Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Nuclear Receptor ROR Gamma Distributors List
14.3 Nuclear Receptor ROR Gamma Customers
15 Market Dynamics
15.1 Nuclear Receptor ROR Gamma Market Trends
15.2 Nuclear Receptor ROR Gamma Drivers
15.3 Nuclear Receptor ROR Gamma Market Challenges
15.4 Nuclear Receptor ROR Gamma Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Nuclear Receptor ROR Gamma Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Nuclear Receptor ROR Gamma Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Nuclear Receptor ROR Gamma Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Nuclear Receptor ROR Gamma Sales (K Pcs) by Region (2016-2021)
Table 5. Global Nuclear Receptor ROR Gamma Sales Market Share by Region (2016-2021)
Table 6. Global Nuclear Receptor ROR Gamma Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Nuclear Receptor ROR Gamma Revenue Share by Region (2016-2021)
Table 8. Global Nuclear Receptor ROR Gamma Sales (K Pcs) Forecast by Region (2022-2027)
Table 9. Global Nuclear Receptor ROR Gamma Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Nuclear Receptor ROR Gamma Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Nuclear Receptor ROR Gamma Revenue Share Forecast by Region (2022-2027)
Table 12. Global Nuclear Receptor ROR Gamma Sales (K Pcs) of Key Companies (2016-2021)
Table 13. Global Nuclear Receptor ROR Gamma Sales Share by Company (2016-2021)
Table 14. Global Nuclear Receptor ROR Gamma Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Nuclear Receptor ROR Gamma Revenue Share by Company (2016-2021)
Table 16. Global Nuclear Receptor ROR Gamma by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Receptor ROR Gamma as of 2020)
Table 17. Global Nuclear Receptor ROR Gamma Average Price (USD/Pcs) of Key Company (2016-2021)
Table 18. Manufacturers Nuclear Receptor ROR Gamma Manufacturing Sites and Area Served
Table 19. Manufacturers Nuclear Receptor ROR Gamma Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Nuclear Receptor ROR Gamma Sales (K Pcs) by Type (2016-2021)
Table 22. Global Nuclear Receptor ROR Gamma Sales Share by Type (2016-2021)
Table 23. Global Nuclear Receptor ROR Gamma Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Nuclear Receptor ROR Gamma Price (USD/Pcs) by Type (2016-2021)
Table 25. Global Nuclear Receptor ROR Gamma Sales Share by Type (2022-2027)
Table 26. Global Nuclear Receptor ROR Gamma Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Nuclear Receptor ROR Gamma Revenue Share by Type (2022-2027)
Table 28. Global Nuclear Receptor ROR Gamma Price (USD/Pcs) by Type (2022-2027)
Table 29. Global Nuclear Receptor ROR Gamma Sales (K Pcs) by Application (2016-2021)
Table 30. Global Nuclear Receptor ROR Gamma Sales Share by Application (2016-2021)
Table 31. Global Nuclear Receptor ROR Gamma Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Nuclear Receptor ROR Gamma Price (USD/Pcs) by Application (2016-2021)
Table 33. Global Nuclear Receptor ROR Gamma Sales (K Pcs) by Application (2022-2027)
Table 34. Global Nuclear Receptor ROR Gamma Sales Share by Application (2022-2027)
Table 35. Global Nuclear Receptor ROR Gamma Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Nuclear Receptor ROR Gamma Revenue Share by Application (2022-2027)
Table 37. Global Nuclear Receptor ROR Gamma Price (USD/Pcs) by Application (2022-2027)
Table 38. North America Nuclear Receptor ROR Gamma Sales (K Pcs) by Company (2016-2021)
Table 39. North America Nuclear Receptor ROR Gamma Sales Market Share by Company (2016-2021)
Table 40. North America Nuclear Receptor ROR Gamma Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Nuclear Receptor ROR Gamma Revenue Market Share by Company (2016-2021)
Table 42. North America Nuclear Receptor ROR Gamma Sales by Type (2016-2021) & (K Pcs)
Table 43. North America Nuclear Receptor ROR Gamma Sales Market Share by Type (2016-2021)
Table 44. North America Nuclear Receptor ROR Gamma Sales by Type (2022-2027) & (K Pcs)
Table 45. North America Nuclear Receptor ROR Gamma Sales Market Share by Type (2022-2027)
Table 46. North America Nuclear Receptor ROR Gamma Sales by Application (2016-2021) & (K Pcs)
Table 47. North America Nuclear Receptor ROR Gamma Sales Market Share by Application (2016-2021)
Table 48. North America Nuclear Receptor ROR Gamma Sales by Application (2022-2027) & (K Pcs)
Table 49. North America Nuclear Receptor ROR Gamma Sales Market Share by Application (2022-2027)
Table 50. Europe Nuclear Receptor ROR Gamma Sales (K Pcs) by Company (2016-2021)
Table 51. Europe Nuclear Receptor ROR Gamma Sales Market Share by Company (2016-2021)
Table 52. Europe Nuclear Receptor ROR Gamma Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Nuclear Receptor ROR Gamma Revenue Market Share by Company (2016-2021)
Table 54. Europe Nuclear Receptor ROR Gamma Sales by Type (2016-2021) & (K Pcs)
Table 55. Europe Nuclear Receptor ROR Gamma Sales Market Share by Type (2016-2021)
Table 56. Europe Nuclear Receptor ROR Gamma Sales by Type (2022-2027) & (K Pcs)
Table 57. Europe Nuclear Receptor ROR Gamma Sales Market Share by Type (2022-2027)
Table 58. Europe Nuclear Receptor ROR Gamma Sales by Application (2016-2021) & (K Pcs)
Table 59. Europe Nuclear Receptor ROR Gamma Sales Market Share by Application (2016-2021)
Table 60. Europe Nuclear Receptor ROR Gamma Sales by Application (2022-2027) & (K Pcs)
Table 61. Europe Nuclear Receptor ROR Gamma Sales Market Share by Application (2022-2027)
Table 62. China Nuclear Receptor ROR Gamma Sales (K Pcs) by Company (2016-2021)
Table 63. China Nuclear Receptor ROR Gamma Sales Market Share by Company (2016-2021)
Table 64. China Nuclear Receptor ROR Gamma Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Nuclear Receptor ROR Gamma Revenue Market Share by Company (2016-2021)
Table 66. China Nuclear Receptor ROR Gamma Sales by Type (2016-2021) & (K Pcs)
Table 67. China Nuclear Receptor ROR Gamma Sales Market Share by Type (2016-2021)
Table 68. China Nuclear Receptor ROR Gamma Sales by Type (2022-2027) & (K Pcs)
Table 69. China Nuclear Receptor ROR Gamma Sales Market Share by Type (2022-2027)
Table 70. China Nuclear Receptor ROR Gamma Sales by Application (2016-2021) & (K Pcs)
Table 71. China Nuclear Receptor ROR Gamma Sales Market Share by Application (2016-2021)
Table 72. China Nuclear Receptor ROR Gamma Sales by Application (2022-2027) & (K Pcs)
Table 73. China Nuclear Receptor ROR Gamma Sales Market Share by Application (2022-2027)
Table 74. Japan Nuclear Receptor ROR Gamma Sales (K Pcs) by Company (2016-2021)
Table 75. Japan Nuclear Receptor ROR Gamma Sales Market Share by Company (2016-2021)
Table 76. Japan Nuclear Receptor ROR Gamma Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Nuclear Receptor ROR Gamma Revenue Market Share by Company (2016-2021)
Table 78. Japan Nuclear Receptor ROR Gamma Sales by Type (2016-2021) & (K Pcs)
Table 79. Japan Nuclear Receptor ROR Gamma Sales Market Share by Type (2016-2021)
Table 80. Japan Nuclear Receptor ROR Gamma Sales by Type (2022-2027) & (K Pcs)
Table 81. Japan Nuclear Receptor ROR Gamma Sales Market Share by Type (2022-2027)
Table 82. Japan Nuclear Receptor ROR Gamma Sales by Application (2016-2021) & (K Pcs)
Table 83. Japan Nuclear Receptor ROR Gamma Sales Market Share by Application (2016-2021)
Table 84. Japan Nuclear Receptor ROR Gamma Sales by Application (2022-2027) & (K Pcs)
Table 85. Japan Nuclear Receptor ROR Gamma Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Nuclear Receptor ROR Gamma Sales (K Pcs) by Company (2016-2021)
Table 87. Southeast Asia Nuclear Receptor ROR Gamma Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Nuclear Receptor ROR Gamma Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Nuclear Receptor ROR Gamma Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Nuclear Receptor ROR Gamma Sales by Type (2016-2021) & (K Pcs)
Table 91. Southeast Asia Nuclear Receptor ROR Gamma Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Nuclear Receptor ROR Gamma Sales by Type (2022-2027) & (K Pcs)
Table 93. Southeast Asia Nuclear Receptor ROR Gamma Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Nuclear Receptor ROR Gamma Sales by Application (2016-2021) & (K Pcs)
Table 95. Southeast Asia Nuclear Receptor ROR Gamma Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Nuclear Receptor ROR Gamma Sales by Application (2022-2027) & (K Pcs)
Table 97. Southeast Asia Nuclear Receptor ROR Gamma Sales Market Share by Application (2022-2027)
Table 98. India Nuclear Receptor ROR Gamma Sales (K Pcs) by Company (2016-2021)
Table 99. India Nuclear Receptor ROR Gamma Sales Market Share by Company (2016-2021)
Table 100. India Nuclear Receptor ROR Gamma Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Nuclear Receptor ROR Gamma Revenue Market Share by Company (2016-2021)
Table 102. India Nuclear Receptor ROR Gamma Sales by Type (2016-2021) & (K Pcs)
Table 103. India Nuclear Receptor ROR Gamma Sales Market Share by Type (2016-2021)
Table 104. India Nuclear Receptor ROR Gamma Sales by Type (2022-2027) & (K Pcs)
Table 105. India Nuclear Receptor ROR Gamma Sales Market Share by Type (2022-2027)
Table 106. India Nuclear Receptor ROR Gamma Sales by Application (2016-2021) & (K Pcs)
Table 107. India Nuclear Receptor ROR Gamma Sales Market Share by Application (2016-2021)
Table 108. India Nuclear Receptor ROR Gamma Sales by Application (2022-2027) & (K Pcs)
Table 109. India Nuclear Receptor ROR Gamma Sales Market Share by Application (2022-2027)
Table 110. Genfit SA Corporation Information
Table 111. Genfit SA Description and Business Overview
Table 112. Genfit SA Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. Genfit SA Nuclear Receptor ROR Gamma Product
Table 114. Genfit SA Recent Development
Table 115. GlaxoSmithKline Plc Corporation Information
Table 116. GlaxoSmithKline Plc Description and Business Overview
Table 117. GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Product
Table 119. GlaxoSmithKline Plc Recent Development
Table 120. Aurigene Discovery Technologies Corporation Information
Table 121. Aurigene Discovery Technologies Description and Business Overview
Table 122. Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Product
Table 124. Aurigene Discovery Technologies Recent Development
Table 125. Beijing Hanmi Pharmaceutical Corporation Information
Table 126. Beijing Hanmi Pharmaceutical Description and Business Overview
Table 127. Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Product
Table 129. Beijing Hanmi Pharmaceutical Recent Development
Table 130. Biogen Inc Corporation Information
Table 131. Biogen Inc Description and Business Overview
Table 132. Biogen Inc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 133. Biogen Inc Nuclear Receptor ROR Gamma Product
Table 134. Biogen Inc Recent Development
Table 135. AbbVie Inc Corporation Information
Table 136. AbbVie Inc Description and Business Overview
Table 137. AbbVie Inc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 138. AbbVie Inc Nuclear Receptor ROR Gamma Product
Table 139. AbbVie Inc Recent Development
Table 140. Eurofins Advinus Corporation Information
Table 141. Eurofins Advinus Description and Business Overview
Table 142. Eurofins Advinus Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 143. Eurofins Advinus Nuclear Receptor ROR Gamma Product
Table 144. Eurofins Advinus Recent Development
Table 145. Brickell Biotech Inc Corporation Information
Table 146. Brickell Biotech Inc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 147. Brickell Biotech Inc Description and Business Overview
Table 148. Brickell Biotech Inc Nuclear Receptor ROR Gamma Product
Table 149. Brickell Biotech Inc Recent Development
Table 150. Pfizer Inc Corporation Information
Table 151. Pfizer Inc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 152. Pfizer Inc Description and Business Overview
Table 153. Pfizer Inc Nuclear Receptor ROR Gamma Product
Table 154. Pfizer Inc Recent Development
Table 155. Phenex Pharmaceuticals AG Corporation Information
Table 156. Phenex Pharmaceuticals AG Description and Business Overview
Table 157. Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 158. Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Product
Table 159. Phenex Pharmaceuticals AG Recent Development
Table 160. Reata Pharmaceuticals Inc Corporation Information
Table 161. Reata Pharmaceuticals Inc Description and Business Overview
Table 162. Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 163. Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Product
Table 164. Reata Pharmaceuticals Inc Recent Development
Table 165. Bristol-Myers Squibb Company Corporation Information
Table 166. Bristol-Myers Squibb Company Description and Business Overview
Table 167. Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 168. Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Product
Table 169. Bristol-Myers Squibb Company Recent Development
Table 170. Celgene Corp Corporation Information
Table 171. Celgene Corp Description and Business Overview
Table 172. Celgene Corp Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 173. Celgene Corp Nuclear Receptor ROR Gamma Product
Table 174. Celgene Corp Recent Development
Table 175. Eli Lilly Corporation Information
Table 176. Eli Lilly Description and Business Overview
Table 177. Eli Lilly Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 178. Eli Lilly Nuclear Receptor ROR Gamma Product
Table 179. Eli Lilly Recent Development
Table 180. Glenmark Pharmaceuticals Corporation Information
Table 181. Glenmark Pharmaceuticals Description and Business Overview
Table 182. Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 183. Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Product
Table 184. Glenmark Pharmaceuticals Recent Development
Table 185. Lead Pharma Holding BV Corporation Information
Table 186. Lead Pharma Holding

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs